IKEDA KENJI 池田賢二

… Alternative Names

IKEDA Kenji 池田賢二

Less

Researcher Number	10434812
Other IDs
Affiliation (Current)	2025: 大阪大学, 大学院薬学研究科, 教授
Affiliation (based on the past Project Information) *help	2022: 大阪大学, 大学院薬学研究科, 教授 2019 – 2021: 国際医療福祉大学, 薬学部, 准教授 2015 – 2017: 大阪大谷大学, 薬学部, 准教授 2012 – 2014: 大阪大谷大学, 薬学部, 講師 2011: 大阪大谷大学, 薬学部, 助教
Review Section/Research Field	Principal Investigator Medical pharmacy / Basic Section 47060:Clinical pharmacy-related
Keywords	Principal Investigator 妊娠時薬物療法 / iPS細胞 / iPS / 胎児移行性 / 胎盤関門 / トロホブラスト / 胎盤 / ファーマコメトリクス / 臨床薬物動態学 / 胎盤薬物透過性 … More / 胎盤薬物透過 / Simcyp / Placental transport / 薬物動態 / Drug Placental Transport / 評価モデル / 薬物透過性 / トランスポーター / レチノイン酸 / シンシチオトロホブラスト / 分化 / 透過モデル / 物質透過モデル / 胎盤透過 / JEG-3 / DJEG / BCRP / 物質透過 / モデル Less

Comprehensive drug placental permeability evaluation using iPS cells-derived drug placental permeability evaluation modelPrincipal Investigator
- Principal Investigator
  
  IKEDA Kenji
- Project Period (FY)
  2019 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Osaka University
  International University of Health and Welfare
Approach for Differentiating Trophoblast Cell Lineage from Human Induced Pluripotent Stem Cells with Retinoic AcidPrincipal Investigator
- Principal Investigator
  
  Ikeda Kenji
- Project Period (FY)
  2014 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Osaka Ohtani University
In vitro approaches to evaluate placental drug transport by using differentiating JEG-3 human choriocarcinoma cellsPrincipal Investigator
- Principal Investigator
  
  IKEDA Kenji
- Project Period (FY)
  2011 – 2013
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Osaka Ohtani University

All 2022 2021 2017 2016 2015 2014 2013 2012 2011 Other

All Journal Article Presentation Book

[Book] 抗菌薬TDM臨床実践ガイドライン2022
- Author(s)
  竹末芳生、池田賢二、木村利美、加藤隆児他
- Total Pages
  216
- Publisher
  公益社団法人日本化学療法学会
- Data Source
  KAKENHI-PROJECT-19K16430
[Journal Article] Carrier-Mediated Placental Transport of Cimetidine and Valproic Acid across Differentiating JEG-3 Cell Layers2015
- Author(s)
  Kenji Ikeda
- Journal Title
  
  Pharmazie
  
  Volume: 70 Pages: 471-476
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26460242
[Journal Article] Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model.2012
- Author(s)
  Kenji IKEDA
- Journal Title
  
  Pharmazie
  
  Volume: 67 Pages: 86-90
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590207
[Journal Article] Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model2012
- Author(s)
  池田賢二、山﨑恭平、保米本愛美、山上聡子、小川雅史、中尾絵莉奈、福永悠海、中西剛、宇都口直樹、名德倫明、廣谷芳彦
- Journal Title
  
  Pharmazie
  
  Volume: 67巻 Pages: 88-90
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590207
[Journal Article] In Vitro Approaches to Evaluate Placental Drug Transport by Using Differentiating JEG-3 Human Choriocarcinoma Cells2011
- Author(s)
  池田賢二、宇都口直樹、筒居秀伸、山上聡子、保米本愛美、中尾絵莉奈、福永悠海、山﨑恭平、名德倫明、廣谷芳彦
- Journal Title
  
  Basic Clin. Pharmacol. Toxicol
  
  Volume: 108巻 Pages: 138-145
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] 周産期医療と薬物療法2022
- Author(s)
  池田　賢二
- Organizer
  2022年度大阪大学薬学部・薬友会卒後研修会第3回
- Invited
- Data Source
  KAKENHI-PROJECT-19K16430
[Presentation] Population pharmacokinetic-pharmacodynamic (PopPK/PD)解析臨床応用に向けての薬剤部門支援システム薬物動態領域試作構築2022
- Author(s)
  池田　賢二
- Organizer
  第42回医療情報学連合大会（第23回日本医療情報学会学術大会）
- Data Source
  KAKENHI-PROJECT-19K16430
[Presentation] 2020年度抗がん薬TDMコントロールサーベイ結果報告2021
- Author(s)
  池田　賢二
- Organizer
  第6回TDM-QC研究会
- Data Source
  KAKENHI-PROJECT-19K16430
[Presentation] TDM国内QCサーベイの紹介と今後の展望2021
- Author(s)
  池田　賢二
- Organizer
  第37回日本TDM学会・学術大会
- Data Source
  KAKENHI-PROJECT-19K16430
[Presentation] iPS細胞を用いたin vitro医薬品胎児移行性評価系の構築に関する検討2017
- Author(s)
  池田賢二
- Organizer
  第38回白金シンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-26460242
[Presentation] In vitro approach for placental drug transport studies using induced pluripotent stem cells.2017
- Author(s)
  Kenji Ikeda
- Organizer
  15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology　(IATDMCT), in Kyoto.
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26460242
[Presentation] iPS細胞を用いたin vitro医薬品胎児移行性評価系の構築に関する検討2017
- Author(s)
  池田　賢二
- Organizer
  第38回白金シンポジウム
- Place of Presentation
  北里大学薬学部２２０２講義室
- Invited
- Data Source
  KAKENHI-PROJECT-26460242
[Presentation] iPS細胞を用いたin vitro 医薬品胎児移行性評価系の確立に関する検討～その２遺伝子解析から～2016
- Author(s)
  池田　賢二、川崎　由栞、松田　仁美、浦嶋　庸子、廣谷　芳彦
- Organizer
  第２６回日本医療薬学会
- Place of Presentation
  国立京都国際会館
- Data Source
  KAKENHI-PROJECT-26460242
[Presentation] iPS細胞を用いたin vitro 医薬品胎児移行性評価系の確立に関する検討～その１機能解析から～2016
- Author(s)
  川崎　由栞、池田　賢二、松田　仁美、浦嶋　庸子、廣谷　芳彦
- Organizer
  第２６回日本医療薬学会
- Place of Presentation
  国立京都国際会館
- Data Source
  KAKENHI-PROJECT-26460242
[Presentation] 物理化学領域と薬学実務領域との連動に迫る2016
- Author(s)
  池田　賢二
- Organizer
  日本薬学会第１３６年会（横浜）シンポジウム
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2016-03-27
- Invited
- Data Source
  KAKENHI-PROJECT-26460242
[Presentation] In vitro Approach for the Placental Drug Transport Evaluation Model Using Induced Pluripotent Stem Cells2015
- Author(s)
  Kenji Ikeda
- Organizer
  14th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology　(IATDMCT)
- Place of Presentation
  The conference venue "De Doelen", Rotterdam, Netherlands
- Year and Date
  2015-10-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26460242
[Presentation] In vitro胎盤薬物透過評価系細胞層におけるリアルタイム経上皮電気抵抗値測定2014
- Author(s)
  池田賢二
- Organizer
  第３１回日本ＴＤＭ学会
- Place of Presentation
  ソラシティカンファレンスセンター（東京）
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] Effect of Breast Cancer Resistance Protein on Cimetidine Transport across the Placental model using Differentiating Human Choriocarcinoma JEG-3 Cells2013
- Author(s)
  池田賢二
- Organizer
  13th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology
- Place of Presentation
  Grand America Hotel, Salt Lake City, USA
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] Effect of Breast Cancer Resistance Protein on Cimetidine Transport across the Placental model using Differentiating Human Choriocarcinoma JEG-3 Cells2013
- Author(s)
  池田賢二
- Organizer
  13th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT)
- Place of Presentation
  Grand America Hotel, Salt Lake City, USA
- Year and Date
  2013-09-26
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] 新規in vitro胎盤薬物透過評価モデルにおける物質透過機能解析2012
- Author(s)
  寺尾佳子、池田賢二, 他
- Organizer
  第62回日本薬学会近畿支部総会・大会
- Place of Presentation
  武庫川女子大学・薬学部
- Year and Date
  2012-10-20
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] 医薬品の胎児移行性評価に適う細胞層モデルの検討2012
- Author(s)
  池田賢二
- Organizer
  日本薬学会第132年会シンポジウム(妊娠時薬物療法に関わる基礎と臨床の情報共有機会拡大に関する提言)
- Place of Presentation
  北海道大学
- Year and Date
  2012-03-31
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] ヒト由来がん細胞株の増殖率に及ぼす各種培養条件の影響2012
- Author(s)
  小宮山水智、池田賢二, 他
- Organizer
  第22回日本医療薬学会年会
- Place of Presentation
  新潟朱鷺メッセ
- Year and Date
  2012-10-28
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] ヒト絨毛癌細胞株JEG-3及びBeWo細胞層の胎盤薬物透過モデルにおける有用性の比較2011
- Author(s)
  山上聡子、池田賢二, 他
- Organizer
  第21回日本医療薬学会年会
- Place of Presentation
  神戸国際会議場
- Year and Date
  2011-10-01
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] 分化JEG-3細胞株によるIn vitro胎盤薬物透過評価モデルを用いたSSRIおよび睡眠剤の栄養膜透過に関する検討2011
- Author(s)
  山﨑恭平、池田賢二, 他
- Organizer
  第21回日本医療薬学会年会
- Place of Presentation
  神戸国際会議場
- Year and Date
  2011-10-01
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] 医薬品医療機器総合機構発出医薬品情報の周知方法に関する検討2011
- Author(s)
  福永悠海、池田賢二, 他
- Organizer
  第21回日本医療薬学会年会
- Place of Presentation
  神戸国際会議場
- Year and Date
  2011-10-01
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] ヒト絨毛癌細胞株BeWoとJEG-3のBreast Cancer Resistance Protein遺伝子多型判定について2011
- Author(s)
  保米本愛美、池田賢二, 他
- Organizer
  第21回日本医療薬学会年会
- Place of Presentation
  神戸国際会議場
- Year and Date
  2011-10-01
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] 分化させたヒト絨毛癌細胞株JEG-3のMultidrug associated protein発現誘導の比較検討2011
- Author(s)
  中尾絵莉奈、池田賢二, 他
- Organizer
  第21回日本医療薬学会年会
- Place of Presentation
  神戸国際会議場
- Year and Date
  2011-10-01
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] 妊娠時薬物療法に関わる基礎と臨床の情報共有機会拡大に関する提言-医薬品の胎児移行性評価に適う細胞層モデルの検討-
- Author(s)
  池田　賢二
- Organizer
  第132回日本薬学会年会シンポジウム42(招待講演)
- Place of Presentation
  北海道大学
- Data Source
  KAKENHI-PROJECT-23590207
[Presentation] In vitro胎盤薬物透過評価系細胞層におけるリアルタイム経上皮電気抵抗値測定
- Author(s)
  池田賢二, 八木裕太, 小倉晴可, 植田ちづる, 川西園代, 初田泰敏, 西井諭司, 小川雅史
- Organizer
  第３１回日本ＴＤＭ学会
- Place of Presentation
  ソラシティカンファレンスセンター
- Year and Date
  2014-05-31 – 2014-06-01
- Data Source
  KAKENHI-PROJECT-26460242

1. UTOGUCHI Naoki (80276633)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
2. HIROTANI Yoshihiko (00351487)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
3. MYOTOKU Michiaki (30469233)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
4. URASHIMA Yoko (90636309)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
5. OGAWA Masafumi

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

IKEDA KENJI 池田 賢二

IKEDA Kenji 池田 賢二

Research Projects

Research Products

Co-Researchers

Comprehensive drug placental permeability evaluation using iPS cells-derived drug placental permeability evaluation modelPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Approach for Differentiating Trophoblast Cell Lineage from Human Induced Pluripotent Stem Cells with Retinoic AcidPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

In vitro approaches to evaluate placental drug transport by using differentiating JEG-3 human choriocarcinoma cellsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 抗菌薬TDM臨床実践ガイドライン2022

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] Carrier-Mediated Placental Transport of Cimetidine and Valproic Acid across Differentiating JEG-3 Cell Layers2015

Author(s)

Journal Title

Data Source

[Journal Article] Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model.2012

Author(s)

Journal Title

Data Source

[Journal Article] Efflux transporter mRNA expression profiles in differentiating JEG-3 human choriocarcinoma cells as a placental transport model2012

Author(s)

Journal Title

Data Source

[Journal Article] In Vitro Approaches to Evaluate Placental Drug Transport by Using Differentiating JEG-3 Human Choriocarcinoma Cells2011

Author(s)

Journal Title

Data Source

[Presentation] 周産期医療と薬物療法2022

Author(s)

Organizer

Data Source

[Presentation] Population pharmacokinetic-pharmacodynamic (PopPK/PD)解析臨床応用に向けての薬剤部門支援システム薬物動態領域試作構築2022

Author(s)

Organizer

Data Source

[Presentation] 2020年度抗がん薬TDMコントロールサーベイ結果報告2021

Author(s)

Organizer

Data Source

[Presentation] TDM国内QCサーベイの紹介と今後の展望2021

Author(s)

Organizer

Data Source

[Presentation] iPS細胞を用いたin vitro医薬品胎児移行性評価系の構築に関する検討2017

Author(s)

Organizer

Data Source

[Presentation] In vitro approach for placental drug transport studies using induced pluripotent stem cells.2017

Author(s)

Organizer

Data Source

[Presentation] iPS細胞を用いたin vitro医薬品胎児移行性評価系の構築に関する検討2017

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] iPS細胞を用いたin vitro 医薬品胎児移行性評価系の確立に関する検討～その２遺伝子解析から～2016

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] iPS細胞を用いたin vitro 医薬品胎児移行性評価系の確立に関する検討～その１機能解析から～2016

Author(s)

IKEDA KENJI 池田賢二

IKEDA Kenji 池田賢二